Economic cost and sustainability of oral therapies in precision oncology

JCO Oncology Practice

12 August 2022 - Precision oncology promises improved outcomes but the cost effectiveness and accessibility of targeted therapies is debatable. 

We report price change patterns from 2015 to 2019 for several oral anticancer medications for common solid tumour malignancies.

Read JCO Oncology Practice article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US , Affordability